Come up with a name for your new list and we'll add to it:
Neurokin raised a round of funding on November 29, 2017. Investors include
Inserm Transfert Initiative.
Neurokin is a biotechnology company that engages in the development of various pharmacological in vitro platforms and in vivo experimental models related to acute neurological diseases. The company de…